We are live on ! Find out more
LUXA

Lux Health Tech Acquisition Corp. Class A Common Stock

Delisted

LUXA was delisted on the 28th of October, 2022.

72 hedge funds and large institutions have $301M invested in Lux Health Tech Acquisition Corp. Class A Common Stock in 2022 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more funds holding

Funds holding: 7172 (+1)

8% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 12

4% more capital invested

Capital invested by funds: $290M → $301M (+$10.9M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

20% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 15

74% less call options, than puts

Call options by funds: $101K | Put options by funds: $393K

Holders
72
Holders Change
+1
Holders Change %
+1.41%
% of All Funds
1.24%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
13
Increased
12
Reduced
15
Closed
12
Calls
$101K
Puts
$393K
Net Calls
-$292K
Net Calls Change
-$34K
Name Holding Trade Value Shares
Change
Change in
Stake
RL
51
RPO LLC
Connecticut
$697K +$693K +69,611 New
DFCM
52
Dark Forest Capital Management
Puerto Rico
$550K
CCM
53
CAAS Capital Management
New York
$523K
Geode Capital Management
54
Geode Capital Management
Massachusetts
$473K
HF
55
HRT Financial
New York
$469K -$239 -24 -0.1%
EC
56
Elequin Capital
New York
$416K -$84.1K -8,455 -17%
Susquehanna International Group
57
Susquehanna International Group
Pennsylvania
$302K -$1.14M -114,847 -79%
SSA
58
Schonfeld Strategic Advisors
New York
$300K -$283K -28,477 -49%
LCM
59
Landscape Capital Management
New Jersey
$257K +$256K +25,689 New
SC
60
Sagefield Capital
Texas
$190K
WAM
61
Warberg Asset Management
Illinois
$189K +$188K +18,900 New
MIG
62
Mariner Investment Group
New York
$159K
PAG
63
Private Advisor Group
New Jersey
$139K
TCM
64
Tuttle Capital Management
Connecticut
$132K -$169K -16,956 -56%
BlackRock
65
BlackRock
New York
$106K +$106K +10,602 New
AI
66
Arena Investors
New York
$105K
UBS Group
67
UBS Group
Switzerland
$48K -$13.7K -1,377 -22%
WAM
68
Wolverine Asset Management
Illinois
$34K -$429K -43,136 -93%
Bank of Montreal
69
Bank of Montreal
Ontario, Canada
$10K -$795K -79,900 -7%
CS
70
Clear Street
New York
$1K +$746 +75 New
D.E. Shaw & Co
71
D.E. Shaw & Co
New York
-$9.8M -991,420 Closed
ECU
72
Eisler Capital (UK)
United Kingdom
-$7.17M -725,000 Closed
JG
73
Jefferies Group
New York
-$3.26M -330,108 Closed
SFM
74
Spartan Fund Management
Canada
-$2.24M -226,753 Closed
SCM
75
Shaolin Capital Management
Florida
-$989K -100,000 Closed

LUXA Hedge Fund Activity: Q3 2022 in Review

72 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) for Q3 2022, worth a combined $301M — up 3.7% from $290M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new LUXA positions and 12 closed out — a net gain of 1 holder — while 12 added to existing stakes and 15 trimmed.

The largest buyer was Mizuho Markets Americas, opening a new position worth an estimated $12.4M. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $9.8M sold.

  • 72 institutional investors held Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) as of Q3 2022, up from 71 in Q2 2022.
  • Funds reported $301M of Lux Health Tech Acquisition Corp. Class A Common Stock stock for Q3 2022, up 3.7% quarter-over-quarter.
  • 13 funds opened new Lux Health Tech Acquisition Corp. Class A Common Stock positions in Q3 2022 and 12 closed out, a net change of +1 holder.
  • The largest Lux Health Tech Acquisition Corp. Class A Common Stock buyer in Q3 2022 was Mizuho Markets Americas, an estimated $12.4M added.
  • The largest Lux Health Tech Acquisition Corp. Class A Common Stock seller in Q3 2022 was D.E. Shaw & Co, an estimated $9.8M sold.

Based on aggregated 13F filings for Q3 2022.